Yatharth Hospital & Trauma Care Services Ltd
YATHARTHYatharth Hospital & Trauma Care Services Ltd is strength at full price. The numbers are improving — and a P/E at the 85th percentile of its own range says the market knows.
The sharpest disagreement: the engine is strong, but at the 85th percentile of its own range you are paying full price for it.
The price is in a confirmed uptrend (15 weeks in) while the P/E sits at the 85th percentile of its own 3-year range. Underneath, the last four quarters read improving — profit +15.4% year on year, and 85% of the last 3 years' profit arrived as cash. What settles it: whether the earnings grow into the multiple.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Yatharth Hospital & Trauma Care Services Ltd trades at ₹844, in a confirmed uptrend and 15 weeks into that stage. That is +14.2% against its own 200-day average. It sits at 93% of a 52-week range of ₹551 to ₹866. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week.
Today the stock is in a confirmed uptrend — week 15 of stage 2, confirmed. At ₹844 it trades +14.2% versus its 200-day average and sits at 93% of its 52-week range (₹551–₹866).
Against the market, two honest reads. Cumulative: over the last 2.9 years the stock moved +156% while the NIFTY 500 moved +38% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 1 straight week — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/E sits at the 85th percentile of its own range.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Yatharth Hospital & Trauma Care Services Ltd trades at 46.1× P/E, at the pricey end of its own range (85th percentile). Its long-run median P/E is 38.6×, measured across 3.0 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 46.1× is at the pricey end of its own range (85th percentile), against a long-run median of 38.6× measured over 3.0 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +34.3% against a +34.9% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 3y, of the +36.7%/yr price move, ~+21.9%/yr came from earnings growth and ~+14.8 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Yatharth Hospital & Trauma Care Services Ltd reads as mixed on its fundamental arc. Mixed — the growth curves are steadily positive, but ROCE at 12.0% is below the 15% bar this page requires to call it Consistent. The read is built from 9 quarters across 4 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +40.3% | +36.2% | +41.2% | — |
| Profit | +29.8% | +37.1% | +53.4% | — |
| EPS | +34.3% | +21.9% | +10.4% | — |
| Share price | +34.9% | +36.7% | — | — |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
52.0/100 — rank 10 of 19 in Hospitals · 93% evidence confidence
Yatharth Hospital & Trauma Care Services Ltd scores 52.0 out of 100 against the 19 companies it is compared with in Hospitals, ranking 10. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 20.2 + 13.7 + 6.7 + 11.4 = 52. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Yatharth Hospital & Trauma Care Services Ltd reported ₹342 Cr of revenue in the Mar 26 quarter, +47.4% year on year. That is the 12th straight quarter of year-on-year growth. Over 9 years it has compounded at 37.0% a year. The last full year, FY26, came in at ₹1,207 Cr. The last four reported quarters add to ₹1,199 Cr.
Yatharth Hospital & Trauma Care Services Ltd reported ₹342 Cr of revenue in the Mar 26 quarter, +47.4% year on year. That is the 12th straight quarter of year-on-year growth. Over 9 years it has compounded at 37.0% a year. The last full year, FY26, came in at ₹1,207 Cr. The last four reported quarters add to ₹1,199 Cr.
FY26 revenue came in at ₹1,207 Cr (+40.3% on the year), capping 9 years at 37.0% compound. The latest quarter (Mar 26) printed ₹342 Cr, +47.4% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +35.8% growth against the decade's 37.0% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +36.1% over the last 4 quarters against +33.7%/yr over the last 8 — stabilising; TTM profit +31.5% vs +22.5%/yr — accelerating.
→ Revenue grew — did margins hold as it scaled? Next: 23.0% this quarter (−2.0 pp YoY).
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Yatharth Hospital & Trauma Care Services Ltd's operating margin is 23.0% in the Mar 26 quarter, −2.0 percentage points against the same quarter a year ago. Across 10 fiscal years the operating margin has ranged 22.0% to 32.0%. The current quarter sits inside that band.
Yatharth Hospital & Trauma Care Services Ltd's operating margin is 23.0% in the Mar 26 quarter, −2.0 percentage points against the same quarter a year ago. Across 10 fiscal years the operating margin has ranged 22.0% to 32.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 23.0%, −2.0 pp against the same quarter a year ago. Across 10 fiscal years the operating margin has ranged 22.0%–32.0%.
🚨 Why the margin moved: operating margin went −1.2 pp year on year while gross margin went +1.9 pp — the loss came mostly from the gross line: input costs and pricing.
→ Margins slipped — did that reach the bottom line? Next: profit +15.4% in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Yatharth Hospital & Trauma Care Services Ltd earned ₹45.0 Cr of net profit in the Mar 26 quarter, +15.4% year on year. It is the 12th consecutive quarter of growth. Full-year FY26 profit was ₹170 Cr. The 9-year compound rate is 56.6%. That is 13.2% of the quarter's revenue. The same quarter a year earlier earned ₹39.0 Cr.
Yatharth Hospital & Trauma Care Services Ltd earned ₹45.0 Cr of net profit in the Mar 26 quarter, +15.4% year on year. It is the 12th consecutive quarter of growth. Full-year FY26 profit was ₹170 Cr. The 9-year compound rate is 56.6%. That is 13.2% of the quarter's revenue. The same quarter a year earlier earned ₹39.0 Cr.
Mar 26 profit was ₹45.0 Cr, +15.4% year on year — the 12th consecutive quarter of growth. On the full year, FY26 printed ₹170 Cr (+29.8%), and the 9-year compound rate is 56.6%.
Why profit moved: revenue contributed +47.4% and the margin −2.0 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +32.8% vs revenue +35.8%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
→ Profit rose — but did the cash follow? Next: 85% of the last 3 years' profit arrived as cash.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 85% of Yatharth Hospital & Trauma Care Services Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹205 Cr of operating cash against ₹170 Cr of profit. After ₹613 Cr of capital spending, ₹−408 Cr was left as free cash.
FY26: operating cash of ₹205 Cr against reported profit of ₹170 Cr, leaving free cash of ₹−408 Cr after ₹613 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 85% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 85%: the cash cycle tightened 88 days between FY21 and FY26 — cash that used to wait in the cycle now reaches the bank sooner.
Router verdict: the bigger cash user is investment — capital spending ran 7.1× depreciation over three years, so the next section's job is to check what that build-out is buying.
→ So follow the cash to where it goes. Next: ₹1,227 Cr of building over 3 years.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Yatharth Hospital & Trauma Care Services Ltd's cash conversion cycle runs −26 days in FY26, down from 62 days in FY21. Capital spending ran ₹1,227 Cr over the last 3 years. At FY26 sales of ₹1,207 Cr each day of that cycle holds about ₹3.3 Cr, so roughly ₹−86.0 Cr sits inside the business at any moment.
FY26: debtors at 113 days, inventory at 32 days — roughly 1.1 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of −26 days, tighter than FY21's 62.
The full loop: cash goes out to suppliers and production on day 0; stock waits 32 days to sell; customers pay about 113 days after that; and suppliers themselves are paid at 171 days — netting out to the −26-day cycle.
In money terms: at FY26 sales of ₹1,207 Cr, each day of the cycle holds about ₹3.3 Cr — so the −26-day loop keeps roughly ₹−86.0 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹1,227 Cr over the last 3 fiscal years against ₹174 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹102 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
→ Does all this activity actually earn its cost of capital? Next: ROCE is 12% and the ROIC − WACC spread is −1.3 pp.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Yatharth Hospital & Trauma Care Services Ltd earns a ROCE of 12% in FY26. That is up from a trough of 6% in FY19. Return on invested capital clears the cost of that capital by −1.3 percentage points, so growth here is not yet paying for the capital it uses.
FY26 ROCE is 12%, recovered from a FY19 trough of 6% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 14.1% net margin × 0.53× asset turns × 1.28× balance-sheet leverage ≈ 9.6% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 10.7% − 12.0% = a −1.3 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.15.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Yatharth Hospital & Trauma Care Services Ltd carries total debt of ₹264 Cr against shareholder equity of ₹1,807 Cr as of Mar 26, a debt-to-equity of 0.15 — effectively unlevered. On the annual view that ratio went from 2.26 in FY22 to 0.15 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹264 Cr against shareholder equity of ₹1,807 Cr — a debt-to-equity of 0.15. On the annual view, debt-to-equity went from 2.26 (FY22) to 0.15 (FY26). The returns on this page are earned, not borrowed.
→ Who owns this, and are they adding or leaving? Next: Promoters cut 10.7 points over 8 quarters.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 10.7 points of Yatharth Hospital & Trauma Care Services Ltd over 8 quarters, the biggest move on the register. That takes promoters to 55.8% of the company. Domestic institutions moved +1.4 points over the same window, to 10.8%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −10.7 points over 8 quarters to 55.8%; Domestic institutions: +1.4 points over 8 quarters to 10.8%; Foreign institutions: +0.7 points over 8 quarters to 5.6%.
🚨 Why the register moved: promoters drove it (−10.7 points), absorbed on the other side by domestic institutions (+1.4 points) — distribution into the market’s bid.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Yatharth Hospital & Trauma Care Services Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | P/E | Mkt cap | Revenue | EPS | ROCE | Stage |
|---|---|---|---|---|---|---|
| Yatharth Hospital & Trauma Care Services Ltd this page | 46.1× | ₹8,082 Cr | Mixed | |||
| Apollo Hospitals Enterprise Ltd | 64.7× | ₹1.3L Cr | Consistent | |||
| Max Healthcare Institute Ltd | 70.9× | ₹1.1L Cr | Topping out | |||
| Fortis Healthcare Ltd | 67.8× | ₹71,623 Cr | Mixed | |||
| Aster DM Healthcare Ltd | 168.0× | ₹68,483 Cr | No read | |||
| Narayana Hrudayalaya Ltd | 47.1× | ₹40,085 Cr | Turning around | |||
| Global Health Ltd | 66.2× | ₹36,862 Cr | Consistent | |||
| Krishna Institute of Medical Sciences Ltd | 135.0× | ₹33,510 Cr | Mixed | |||
| Rainbow Childrens Medicare Ltd | 59.8× | ₹14,806 Cr | Mixed | |||
| Jupiter Life Line Hospitals Ltd | 55.9× | ₹10,595 Cr | Mixed | |||
| Healthcare Global Enterprises Ltd | 346.0× | ₹9,952 Cr | Mixed | |||
| Kovai Medical Center & Hospital Ltd | 26.2× | ₹6,394 Cr | Consistent | |||
| Artemis Medicare Services Ltd | 41.2× | ₹4,365 Cr | Consistent | |||
| Indraprastha Medical Corporation Ltd | 18.2× | ₹3,342 Cr | Mixed | |||
| Dr Agarwals Eye Hospital Ltd | 34.6× | ₹2,427 Cr | Mixed | |||
| KMC Speciality Hospitals (India) Ltd | 45.0× | ₹2,102 Cr | Turning around | |||
| Sakar Healthcare Ltd | 49.5× | ₹1,785 Cr | Improving | |||
| Shalby Ltd | 47.1× | ₹1,762 Cr | Turning around | |||
| KMC Speciality Hospitals (India) Ltd | 37.0× | ₹1,354 Cr | Turning around | |||
| GPT Healthcare Ltd | 30.4× | ₹1,310 Cr | Turning around |
Frequently asked questions
What is Yatharth Hospital & Trauma Care Services Ltd's share price today?
Yatharth Hospital & Trauma Care Services Ltd trades at ₹844, +34.9% over the past year. The company is valued at ₹8,082 Cr. The stock sits at 93% of its 52-week range of ₹551–₹866, +14.2% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 15 weeks in. — as of 24 July 2026.
What were Yatharth Hospital & Trauma Care Services Ltd's latest quarterly results?
Yatharth Hospital & Trauma Care Services Ltd reported revenue of ₹342 Cr and net profit of ₹45.0 Cr for the Mar 26 quarter. Revenue rose 47.4% and profit rose 15.4% year on year. Earnings per share were ₹4.93. The operating margin was 23.0%, 2.0 pp lower than a year earlier. — as of 24 July 2026.
What is Yatharth Hospital & Trauma Care Services Ltd's revenue?
Yatharth Hospital & Trauma Care Services Ltd reported revenue of ₹342 Cr in the Mar 26 quarter, +47.4% year on year. For the full FY26 fiscal year, revenue was ₹1,207 Cr (+40.3%). Over the last 9 years revenue compounded at 37.0% a year. — as of 24 July 2026.
What is Yatharth Hospital & Trauma Care Services Ltd's profit?
Yatharth Hospital & Trauma Care Services Ltd earned ₹45.0 Cr of net profit in the Mar 26 quarter, +15.4% year on year — the 12th straight quarter of growth. Full-year FY26 profit was ₹170 Cr. The operating margin ran 23.0% in the latest quarter. — as of 24 July 2026.
What is Yatharth Hospital & Trauma Care Services Ltd's market cap?
Yatharth Hospital & Trauma Care Services Ltd's market capitalisation is ₹8,082 Cr at a share price of ₹844. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 24 July 2026.
What is Yatharth Hospital & Trauma Care Services Ltd's P/E ratio?
Yatharth Hospital & Trauma Care Services Ltd trades at a P/E of 46.1×, at the 85th percentile of its own 3-year range, against a long-run median of 38.6×. This is a comparison with the stock's own history, not a value call — as of 24 July 2026.
Does Yatharth Hospital & Trauma Care Services Ltd pay a dividend?
No — Yatharth Hospital & Trauma Care Services Ltd has recorded a dividend payout of 0% of profit in each of its last 10 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 24 July 2026.
Is Yatharth Hospital & Trauma Care Services Ltd overvalued?
On its own history, Yatharth Hospital & Trauma Care Services Ltd looks expensive against its own history: its P/E of 46.1× sits at the 85th percentile of its 3-year range (long-run median 38.6×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 24 July 2026.
Is Yatharth Hospital & Trauma Care Services Ltd growing?
Yes — Yatharth Hospital & Trauma Care Services Ltd is growing: latest-quarter revenue +47.4% year on year, profit +15.4%, and the margin −2.0 pp at 23.0%. The 9-year compound rates are 37.0% (revenue) and 56.6% (profit). The earnings engine currently reads: improving — as of 24 July 2026.
How is Yatharth Hospital & Trauma Care Services Ltd performing?
Yatharth Hospital & Trauma Care Services Ltd is in a confirmed uptrend, 15 weeks in. Its latest quarter's revenue rose 47.4% and profit rose 15.4% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 1 week. — as of 24 July 2026.
What stage is Yatharth Hospital & Trauma Care Services Ltd in?
Mixed — the growth curves are steadily positive, but ROCE at 12.0% is below the 15% bar this page requires to call it Consistent. The read comes from the last 12 quarters of growth (revenue growth +36.1% latest, profit growth +31.5% latest, eps growth +27.6% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 24 July 2026.
Is Yatharth Hospital & Trauma Care Services Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 15 of stage 2), trading +14.2% versus its 200-day average and at 93% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 24 July 2026.
Is Yatharth Hospital & Trauma Care Services Ltd beating the market?
On recent form, yes — Yatharth Hospital & Trauma Care Services Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 2.9 years the stock moved +156% against the NIFTY 500's +38% — ahead of the index over the full window. — as of 24 July 2026.
Will Yatharth Hospital & Trauma Care Services Ltd's share price go up?
This page publishes no price forecast for Yatharth Hospital & Trauma Care Services Ltd. What it measures instead: the share price is ₹844, the price is in a confirmed uptrend 15 weeks in. Its P/E of 46.1× sits at the 85th percentile of its own 3-year range. — as of 24 July 2026.
Who owns Yatharth Hospital & Trauma Care Services Ltd?
Promoters hold 55.8% of Yatharth Hospital & Trauma Care Services Ltd, foreign institutions 5.6%, domestic institutions 10.8% and the public 27.7% (latest quarter). The biggest move on the register over the last two years: Promoters cut 10.7 points over 8 quarters. — as of 24 July 2026.
Does Yatharth Hospital & Trauma Care Services Ltd have too much debt?
No — Yatharth Hospital & Trauma Care Services Ltd's debt-to-equity is 0.15, and operating profit covers the interest bill 42×. FY26 borrowings were ₹264 Cr against equity of ₹1,780 Cr. The returns on this page are earned, not borrowed — as of 24 July 2026.
What is Yatharth Hospital & Trauma Care Services Ltd's capex?
Yatharth Hospital & Trauma Care Services Ltd spent ₹1,227 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. Depreciation over the same years was ₹174 Cr. — as of 24 July 2026.
What is Yatharth Hospital & Trauma Care Services Ltd's cash flow?
Yatharth Hospital & Trauma Care Services Ltd generated ₹205 Cr of operating cash flow in FY26 and ₹−408 Cr of free cash flow after ₹613 Cr of capital spending. Reported profit that year was ₹170 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 24 July 2026.
Is Yatharth Hospital & Trauma Care Services Ltd's profit real cash?
Yes — over the last 3 fiscal years, 85% of Yatharth Hospital & Trauma Care Services Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹205 Cr against reported profit of ₹170 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 24 July 2026.
Where is Yatharth Hospital & Trauma Care Services Ltd in its business cycle?
Yatharth Hospital & Trauma Care Services Ltd's FY26 operating margin was 24.0%, against a 10-year band of 22.0%–32.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 23.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 24 July 2026.
What could break the Yatharth Hospital & Trauma Care Services Ltd story?
The sharpest disagreement: the engine is strong, but at the 85th percentile of its own range you are paying full price for it. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 24 July 2026.
Is Yatharth Hospital & Trauma Care Services Ltd a stock worth studying right now?
This is not investment advice. The machine read: Yatharth Hospital & Trauma Care Services Ltd is strength at full price. The numbers are improving — and a P/E at the 85th percentile of its own range says the market knows. The sharpest open question: whether the earnings grow into the multiple. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 24 July 2026.